OSE Immunotherapeutics: OSE (PAR: OSE) launches AI immunotherapy partnership
OSE has signed a strategic partnership with Scienta Lab, aiming to model inflammatory diseases and identify predictive biomarkers of efficacy for immunotherapies. Scienta Lab is a France-based lead...
Read full article »
OSE Immunotherapeutics is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Read more